SCHOTT Pharma AG & Co. KGaA (ETR:1SXP)
19.44
+0.02 (0.10%)
Last updated: Oct 30, 2025, 11:09 AM CET
ETR:1SXP Revenue
SCHOTT Pharma AG & Co. KGaA had revenue of 256.46M EUR in the quarter ending June 30, 2025, with 1.13% growth. This brings the company's revenue in the last twelve months to 975.68M, up 2.86% year-over-year. In the fiscal year ending September 30, 2024, SCHOTT Pharma AG & Co. KGaA had annual revenue of 957.09M with 6.51% growth.
Revenue (ttm)
975.68M
Revenue Growth
+2.86%
P/S Ratio
3.00
Revenue / Employee
204.33K
Employees
4,690
Market Cap
2.92B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2024 | 957.09M | 58.49M | 6.51% |
| Sep 30, 2023 | 898.60M | 77.46M | 9.43% |
| Sep 30, 2022 | 821.14M | 172.48M | 26.59% |
| Sep 30, 2021 | 648.67M | 64.44M | 11.03% |
| Sep 30, 2020 | 584.23M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bayer Aktiengesellschaft | 46.17B |
| Siemens Healthineers AG | 23.38B |
| Fresenius SE & Co. KGaA | 22.28B |
| Merck KGaA | 21.22B |
| Fresenius Medical Care AG | 19.52B |
| Sartorius Aktiengesellschaft | 3.52B |
| Redcare Pharmacy NV | 2.82B |
| Fielmann Group AG | 2.40B |
SCHOTT Pharma AG & Co. KGaA News
- 23 days ago - EQS-AFR: SCHOTT Pharma AG & Co. KGaA: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act] - Wallstreet:Online
- 4 weeks ago - EQS-PVR: SCHOTT Pharma AG & Co. KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution - Wallstreet:Online
- 2 months ago - EQS-AFR: SCHOTT Pharma AG & Co. KGaA: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act] - Wallstreet:Online
- 2 months ago - EQS-AFR: SCHOTT Pharma AG & Co. KGaA: Preliminary announcement of the publication of quarterly reports and quarterly/interim statements - Wallstreet:Online
- 2 months ago - SCHOTT Pharma's Q3 Success: Strong Results Delivered! - Wallstreet:Online
- 2 months ago - EQS-News: SCHOTT Pharma delivers solid final third-quarter results - Wallstreet:Online
- 3 months ago - SCHOTT Pharma Unveils Q3 2025 Results & FY Guidance - Wallstreet:Online
- 3 months ago - EQS-News: SCHOTT Pharma reports preliminary results for Q3 2025 and specifies FY 2025 guidance - Wallstreet:Online